Chris Conrad

Title: Chris Conrad: Innovator in Neurodegenerative Disease Research

Introduction

Chris Conrad is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of neurodegenerative disease research. With a total of 2 patents, his work focuses on the Saitohin gene and its implications for health.

Latest Patents

Conrad's latest patents include groundbreaking inventions related to the Saitohin gene. The first patent provides an isolated nucleic acid sequence encoding Saitohin (STH), along with a purified protein encoded by this sequence. It also details methods for producing STH protein and an antibody specific for STH. Furthermore, the invention includes a vector comprising a nucleic acid sequence encoding STH, a host cell transformed with this vector, and transgenic nonhuman animals. The patent outlines methods for determining whether a subject has, or is at increased risk for developing, a neurodegenerative disease, as well as kits for assessing this risk.

Career Highlights

Chris Conrad is affiliated with the Albert Einstein College of Medicine, where he continues to advance his research. His work has garnered attention for its potential impact on understanding and treating neurodegenerative diseases.

Collaborations

One of his notable collaborators is Peter Davies, with whom he has worked on various research projects.

Conclusion

Chris Conrad's innovative work in the field of neurodegenerative disease research highlights the importance of genetic studies in medicine. His contributions through patents and collaborations continue to pave the way for advancements in this critical area of health.